Image guided volumetric response during chemoradiotherapy for head and neck squamous cell carcinoma as a predictor of disease outcomes.
OBJECTIVE
The goal of this study was to correlate volumetric image guided disease response to clinical outcomes in patients receiving chemoradiation therapy (CRT) for locally advanced head and neck squamous cell carcinoma (HNSCC).


METHODS
Thirty four patients completing definitive CRT for locally advanced HNSCC with megavoltage computed tomography (MVCT) guided tomotherapy IMRT were retrospectively reviewed for volumetric response. Grossly identifiable primary tumor (PT) and nodal disease (ND) response was evaluated by weekly MVCT regression. Percent end-of-treatment (EOT) residual volumes and regression rates were correlated with risk of local failure (LF), progression free survival (PFS), and overall survival (OS).


RESULTS
A total of 7 LFs were identified in 6 patients at a median follow-up of 8months. The mean percent EOT residual volumes for PT and ND in patients with and without LF were 20% vs. 5% (p=0.005) and 47% vs. 6% (p=0.0001), respectively. The PT and ND volume regression rates for patients with and without LF were 12.7% per week vs. 15.9% per week (p=0.04) and 3.4% per week vs. 10.5% per week (p<0.001), respectively. Utilizing an EOT cut-off value of 25% residual volume, the relative risks of LF for PT and ND were 14.7 (p=0.03) and 25 (p=0.001), respectively. Patients found with PT and/or ND residual volumes <25% at EOT had longer 2year OS of 100% vs. 67% (p=0.0023) and PFS of 87% vs. 17% (p<0.001) compared with patients with residual volumes >/= 25% at EOT.


CONCLUSIONS
Patients with locally advanced HNSCC who have significant MVCT volume reduction over the course of definitive CRT tend to have favorable clinical outcomes.
University of Arizona Cancer Center, Department of Radiation Oncology.
Rajayogesh
R
Davuluri
University of Arizona Cancer Center, Department of Radiation Oncology.
Jeff M
JM
Krase
University of Arizona Cancer Center, Department of Biostatistics.
Haiyan
H
Cui
University of Arizona Cancer Center, Department of Radiation Oncology.
Uma D
UD
Goyal
University of Arizona Cancer Center, Department of Radiation Oncology.
Michael K
MK
Cheung
University of Arizona Cancer Center, Department of Radiation Oncology.
Charles C
CC
Hsu
University of Arizona Cancer Center, Department of Radiation Oncology. Electronic address: sunkyi@email.arizona.edu.
Sun K
SK
Yi
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000401:mortality / Q000628:therapy*; D059248:Chemoradiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D061089:Radiotherapy, Image-Guided; D012189:Retrospective Studies; D000077195:Squamous Cell Carcinoma of Head and Neck; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D047368:Tumor Burden